Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
Bioavailability |
15.0 |
% |
10-20 |
% |
PO, oral; |
DRUGBANK |
C Max |
4600.0 |
ng/ml |
4.6 |
mcg/ml |
PO, oral; |
DRUGBANK |
C Max |
3800.0 |
ng/ml |
3.8 |
mcg/ml |
IM,intramuscular injection; |
DRUGBANK |
T Max |
4.0 |
h |
4 |
h |
PO, oral; |
DRUGBANK |
T Max |
1.5 |
h |
1.5 |
h |
IM,intramuscular injection; |
DRUGBANK |
Tss |
84.0 |
h |
3-4 |
day |
PO, oral; |
DRUGBANK |
Volume of Distribution |
0.40 |
L |
0.4 |
ml/g |
Apparent volume of distribution; IM,intramuscular injection; |
DRUGBANK |
Volume of Distribution |
0.44 |
L |
0.44 |
ml/g |
Apparent volume of distribution; PO, oral; |
DRUGBANK |
Half-life |
15.0 |
h |
15 |
h |
|
DRUGBANK |
Half-life |
15.0 |
h |
15 |
h |
Derivative; |
DRUGBANK |
Half-life |
4.6 |
h |
275 |
min |
elimination half-life; human, homo sapiens; IM,intramuscular injection; |
DRUGBANK |
Half-life |
5.2 |
h |
310 |
min |
elimination half-life; human, homo sapiens; PO, oral; |
DRUGBANK |
Eliminate Route |
37.0 |
% |
~37 |
% |
Urinary excretion; IM,intramuscular injection; |
DRUGBANK |
Protein Binding |
0.23 |
% |
0.23 |
% |
|
DRUGBANK |